Family constellation seminars improve psychological functioning in a general population sample: Results of a randomized controlled trial.

2013 ◽  
Vol 60 (4) ◽  
pp. 601-609 ◽  
Author(s):  
Jan Weinhold ◽  
Christina Hunger ◽  
Annette Bornhäuser ◽  
Leoni Link ◽  
Justine Rochon ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
General Population ◽  
Psychological Functioning ◽  
Controlled Trial ◽  
Population Sample ◽  
General Population Sample ◽  
Randomized Controlled ◽  
Family Constellation

scholarly journals Cognition and obstructive sleep apnoea in Parkinson’s disease, effect of positive airway pressure therapy (COPE-PAP trial): protocol of a randomized controlled trial

2021 ◽  
Vol 8 (1) ◽  
pp. 35
Author(s):  
Annie C. Lajoie ◽  
Annie-Louise Lafontaine ◽  
Gabriel Leonard ◽  
R. John Kimoff ◽  
Andrea Benedetti ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cognitive Function ◽  
General Population ◽  
Cognitive Dysfunction ◽  
Airway Pressure ◽  
Positive Airway Pressure ◽  
Controlled Trial ◽  
Trial Registration ◽  
Randomized Controlled ◽  
Obstructive Sleep

<p class="abstract"><strong>Background:</strong> Parkinson’s disease (PD) is the second most frequent neurodegenerative disease and is associated with cognitive dysfunction. Obstructive sleep apnea (OSA) has been linked with cognitive dysfunction in the general population and in PD. Treatment with positive airway pressure (PAP), can improve cognition in the general population and in patients with other neurodegenerative diseases. However, the effect of PAP therapy on cognitive function has not been well studied in PD.</p><p class="abstract"><strong>Methods:</strong> This randomized controlled trial will assess the effect of 6 months of PAP therapy versus placebo on global cognitive function in PD patients with OSA and reduced baseline cognition. Secondary outcomes will include quality of life and other non-motor symptoms of PD. Exploratory outcomes will be specific domains of neurocognitive function and symptoms of REM sleep behaviour disorder.</p><p class="abstract"><strong>Conclusions: </strong>PD-related cognitive dysfunction often evolves towards dementia and has substantial personal, social and healthcare costs. Few interventions have been shown to improve cognition in PD to date. If positive, results from our study could prove OSA to be a new therapeutic target relevant to cognition and would support more systematic screening for OSA in PD patients with cognitive decline.</p><p class="abstract"><strong>Trial Registration:</strong> Trial registration number is NCT02209363.</p>

A randomized controlled trial of guided imagery in bulimia nervosa

1998 ◽  
Vol 28 (6) ◽  
pp. 1347-1357 ◽  
Author(s):  
M. J. ESPLEN ◽  
P. E. GARFINKEL ◽  
M. OLMSTED ◽  
R. M. GALLOP ◽  
S. KENNEDY
Keyword(s):  
Randomized Controlled Trial ◽  
Bulimia Nervosa ◽  
Psychological Functioning ◽  
Guided Imagery ◽  
Controlled Trial ◽  
Control Group ◽  
Psychological Measures ◽  
Eating Disorder Symptoms ◽  
Randomized Controlled ◽  
Imagery Group

Background. The objective of this study was to test a guided imagery therapy designed to enhance self-comforting in bulimia nervosa.Methods. A randomized controlled trial compared 6 weeks of individual guided imagery therapy with a control group. Fifty participants who met DSM-III-R criteria for bulimia nervosa completed the study. Measures of eating disorder symptoms, psychological functioning and the experience of guided imagery therapy were administered.Results. The guided imagery treatment had substantial effects on the reduction of bingeing and purging episodes; the imagery group had a mean reduction of binges of 74% and of vomiting of 73%. The imagery treatment also demonstrated improvement on measures of attitudes concerning eating, dieting and body weight in comparison to the control group. In addition, the guided imagery demonstrated improvement on psychological measures of aloneness and the ability for self-comforting.Conclusions. Evidence from this study suggests that guided imagery was an effective treatment for bulimia nervosa, at least in the short-term.

Sign in / Sign up

Export Citation Format

Share Document